In the Capital featured GW researchers, who have received more than $13 million in federal funding over the last month. Of the $13 million, $9 million will be to fund research by Matthew Colonnese, Ph.D., assistant professor of pharmacology and physiology, Richard Katz, M.D., Bloedorn Professor of Cardiology, Mandi Pratt-Chapman, M.A., associate director of the GW Cancer Institute, and Dominic Raj, M.D., director of the division of nephrology and professor of medicine.
InTheCapital - GW Researchers Hit the Jackpot With More Than $13 Million in Grants in One Month
Latest News
Basil Considine, a third-year medical student at the George Washington University School of Medicine and Health Sciences (GW SMHS), addressed U.S. Food and Drug Administration (FDA) leadership, pharmaceutical representatives, and association stakeholders during a public meeting regarding the…
The George Washington University School of Medicine and Health Sciences (SMHS) recently honored a pair of accomplished faculty members, Sharad Goyal, MD, and Christina M. Puchalski, MD ’94, RESD ’97, for their academic excellence and leadership in patient care by formally bestowing them with…
The GW Department of Dermatology has been awarded a prestigious Competitive Clinical Research Grant by Eli Lilly and Company to evaluate the effectiveness of Atopic Triad (atopic dermatitis, asthma, and seasonal allergies) screening and education to reduce the burden of Atopic Dermatitis and its…